165 related articles for article (PubMed ID: 28039711)
1. Tumor deposits: Prognostic significance in gastric cancer patients.
Yildiz B; Etiz D; Dal P; Junushova B; Pasaoglu O; Yilmaz E; Erkasap S; Dincer M
J BUON; 2016; 21(6):1476-1481. PubMed ID: 28039711
[TBL] [Abstract][Full Text] [Related]
2. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor deposits in gastric cancer patients who underwent radical surgery.
Sun Z; Wang ZN; Xu YY; Zhu GL; Huang BJ; Xu Y; Liu FN; Zhu Z; Xu HM
Surgery; 2012 Jun; 151(6):871-81. PubMed ID: 22386276
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the impact of tumor deposits on prognosis in gastric cancer and a proposal for their incorporation into the AJCC staging system.
Chen H; Tang Z; Chen L; Li H; Wang X; Liu F; Sun Y
Eur J Surg Oncol; 2018 Dec; 44(12):1990-1996. PubMed ID: 30360989
[TBL] [Abstract][Full Text] [Related]
7. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
[TBL] [Abstract][Full Text] [Related]
9. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.
Wang Z; Zhang X; Hu J; Zeng W; Zhou Z
J Visc Surg; 2015 Dec; 152(6):357-61. PubMed ID: 26481069
[TBL] [Abstract][Full Text] [Related]
11. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
Kim BS; Oh ST; Yook JH; Kim BS
Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
[TBL] [Abstract][Full Text] [Related]
12. Perineural invasion independent prognostic factors in patients with gastric cancer undergoing curative resection.
Selçukbiricik F; Tural D; Büyükünal E; Serdengeçti S
Asian Pac J Cancer Prev; 2012; 13(7):3149-52. PubMed ID: 22994725
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for gastric carcinoma: 10 years follow-up of 244 cases from a single institution.
Misirlioglu HC; Coskun-Breuneval M; Kucukpilakci B; Ugur VI; Elgin Y; Demirkasimoglu T; Kara SP; Ozgen A; Sanri E; Guney Y
Asian Pac J Cancer Prev; 2014; 15(20):8871-6. PubMed ID: 25374221
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with early recurrence after curative surgery for gastric cancer.
Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
16. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
18. Long-term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer.
Nam DH; Lee H; Park JC; Shin SK; Lee SK; Hyung WJ; Lee YC; Kang MW; Noh SH
Anticancer Res; 2014 Jan; 34(1):355-61. PubMed ID: 24403487
[TBL] [Abstract][Full Text] [Related]
19. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
